Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Loquat leaf aqueous extract (LLE) is a botanical preparation derived from the leaves of *Eriobotrya japonica* (the loquat tree) using water as the extraction solvent. The extract contains a complex mixture of bioactive compounds, most notably the pentacyclic triterpenoid ursolic acid, alongside various flavonoids (such as quercetin, rutin, naringenin, and epicatechin), phenolic acids (protocatechuic and chlorogenic acids), saponins, and amygdalin. Preclinical and early clinical research suggests that LLE possesses antidiabetic, antihyperlipidemic, anti-inflammatory, and neuroprotective properties. Its pharmacological activity is attributed to the modulation of multiple biological pathways, including the inhibition of Nuclear factor NF-kappa-B (NF-κB) and Mitogen-activated protein kinase (MAPK) signaling, as well as the regulation of Amyloid-beta precursor protein (APP) processing. While it has been investigated in clinical trials for conditions such as muscle atrophy and diabetes, it is primarily utilized as a traditional medicine ingredient and a dietary supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on loquat leaf aqueous extract.